Literature DB >> 34326713

Thickness and Sphericity Control of Hollow Hard Silica Shells through Iron (III) Doping: Low Threshold Ultrasound Contrast Agents.

Ching-Hsin Huang1, James Wang1, Jian Yang1, Juan Pablo Oviedo2, Seungjin Nam2, William C Trogler1, Sarah L Blair3, Moon J Kim2, Andrew C Kummel1.   

Abstract

Silica particles are convenient ultrasound imaging contrast agents because of their long imaging time and ease of modification; however, they require a relatively high insonation power for imaging and have low biodegradability. In this study, 2 μm ultrathin asymmetric hollow silica particles doped with iron (III) (Fe(III)-SiO2) are synthesized to produce biodegradable hard shelled particles with a low acoustic power threshold comparable with commercial soft microbubble contrast agents (Definity) yet with much longer in vivo ultrasound imaging time. Furthermore, high intensity focused ultrasound ablation enhancement with these particles shows a 2.5-fold higher temperature elevation than with Definity at the same applied power. The low power visualization improves utilization of the silica shells as an adjuvant in localized immunotherapy. The data are consistent with asymmetric engineering of hard particle properties that improve functionality of hard versus soft particles.

Entities:  

Keywords:  asymmetry; hard shells; iron; silica; ultrasound contrast agents

Year:  2019        PMID: 34326713      PMCID: PMC8318338          DOI: 10.1002/adfm.201900893

Source DB:  PubMed          Journal:  Adv Funct Mater        ISSN: 1616-301X            Impact factor:   18.808


  25 in total

1.  In vivo acceleration of ultrasonic tissue heating by microbubble agent.

Authors:  Shin-Ichiro Umemura; Ken-Ichi Kawabata; Kazuaki Sasaki
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2005-10       Impact factor: 2.725

2.  Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial.

Authors:  Hiroji Uemura; Futoshi Sano; Akira Nomiya; Toshihiro Yamamoto; Masafumi Nakamura; Yasuhide Miyoshi; Kenta Miki; Kazumi Noguchi; Shin Egawa; Yukio Homma; Yoshinobu Kubota
Journal:  World J Urol       Date:  2012-02-04       Impact factor: 4.226

Review 3.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.

Authors:  Katherine Ferrara; Rachel Pollard; Mark Borden
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

Review 4.  Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.

Authors:  Sunil Unnikrishnan; Alexander L Klibanov
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

5.  Iron(III)-doped, silica nanoshells: a biodegradable form of silica.

Authors:  Kristina K Pohaku Mitchell; Alexander Liberman; Andrew C Kummel; William C Trogler
Journal:  J Am Chem Soc       Date:  2012-08-16       Impact factor: 15.419

Review 6.  Beyond antigens and adjuvants: formulating future vaccines.

Authors:  Tyson J Moyer; Andrew C Zmolek; Darrell J Irvine
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

7.  High intensity focused ultrasound in clinical tumor ablation.

Authors:  Yu-Feng Zhou
Journal:  World J Clin Oncol       Date:  2011-01-10

8.  Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors.

Authors:  H Paul Martinez; Yuko Kono; Sarah L Blair; Sergio Sandoval; Jessica Wang-Rodriguez; Robert F Mattrey; Andrew C Kummel; William C Trogler
Journal:  Medchemcomm       Date:  2010-10       Impact factor: 3.597

9.  Mechanically Tunable Hollow Silica Ultrathin Nanoshells for Ultrasound Contrast Agents.

Authors:  A Liberman; J Wang; N Lu; R D Viveros; C A Allen; R F Mattrey; S L Blair; W C Trogler; M J Kim; A C Kummel
Journal:  Adv Funct Mater       Date:  2015-05-21       Impact factor: 18.808

Review 10.  Recent advances in molecular, multimodal and theranostic ultrasound imaging.

Authors:  Fabian Kiessling; Stanley Fokong; Jessica Bzyl; Wiltrud Lederle; Moritz Palmowski; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.